ESTRO35 Programme Book

> The impact of chemotherapy on toxicity in the era of hypofractionated radiotherapy M.C. De Santis (Italy), F. Di Salvo, F. Bonfantini, M. Dispinzieri, M. Franceschini, F. Soncini, E.D. Mantero, V. Cosentino, D. Postè, P. Baili, M. Sant, E. Pignoli, L. Lozza > Chest wall radiotherapy and complications after flap reconstruction Y. Rao (USA), A. Mull, A. Qureshi, T. Myckatyn, I. Zoberi > GTV delineation of laryngopharyngeal carcinoma on PET is more accurate than on CT and MRI H. Ligtenberg (The Netherlands), E.A. Jager, J. Caldaz-Magalhaes, T. Schakel, N. Kasperts, F.A. Pameijer, N. Kooij, L.M. Janssen, C.H.J. Terhaard, S.M. Willems, C.P.J. Raaijmakers, M.E.P. Philippens > Guideline development for tumor delineation on MR-images for laryn- geal and hypophargeal cancer E. Jager, N. Raaijmakers (The Netherlands), H. Ligtenberg, J. Caldas-Magalhaes, T. Schakel, F. Pameijer, N. Kasperts, N. Willems, C. Terhaard, M. Philippens > Upfront vs. no upfront neck dissection in primary head and neck cancer radio(chemo)therapy D. Nevens (Belgium), F. Duprez, K. Bonte, P. Deron, W. Huvenne, A. Laenen, W. De Neve, S. Nuyts > Phase 1 study of Debio 1143 in combination with Concurrent Chemo- Radiotherapy in LA-SCCHN Y. Tao (France), C. Le Tourneau, H. Bouchaab, J. Delord, V. Calugaru, P. Crampton, B. Gavillet, E. Rouits, C. Zanna, C. Schusterbauer, E. Deutsch, J. Bourhis > The hypoxic radiosensitizer, nimorazole, in RT of HNSCC: pharmacoki- netics, toxicity and compliance M.A.H. Metwally (Denmark), J. Overgaard

MONDAY 2 MAY 2016

PV-0513

PV-0514

PV-0515

PV-0516

PV-0517

PV-0518

PV-0519

Multidisciplinary Tumour Board SESSION 3: OLIGOMETASTATIC DISEASE 14:30 - 15:45 | ISTANBUL Chair: M. Hoyer (Denmark)

yESTRO Panellist: J-E Bibault (France)

INTERDISCIPLINARY RADIOBIOLOGY

CLINICAL BRACHYTHERAPY PHYSICS

RTT

YOUNG

SCIENTIFIC PROGRAMME | PROGRAMME AND EXHIBITION GUIDE

140